Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1976 2
1977 2
1978 1
1979 2
1980 6
1981 10
1982 5
1983 6
1984 3
1985 1
1986 6
1987 4
1988 4
1989 2
1990 3
1991 3
1992 5
1993 5
1994 3
1995 4
1996 3
1997 3
1998 1
1999 4
2000 2
2001 2
2002 3
2003 11
2004 8
2005 9
2006 11
2007 6
2008 6
2009 15
2010 15
2011 17
2012 21
2013 20
2014 16
2015 14
2016 12
2017 8
2018 6
2019 7
2020 9
2021 7
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

289 results
Results by year
Filters applied: . Clear all
Page 1
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.
Taylor PC, Keystone EC, van der Heijde D, Weinblatt ME, Del Carmen Morales L, Reyes Gonzaga J, Yakushin S, Ishii T, Emoto K, Beattie S, Arora V, Gaich C, Rooney T, Schlichting D, Macias WL, de Bono S, Tanaka Y. Taylor PC, et al. Among authors: keystone ec. N Engl J Med. 2017 Feb 16;376(7):652-662. doi: 10.1056/NEJMoa1608345. N Engl J Med. 2017. PMID: 28199814 Free article. Clinical Trial.
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Combe B, Kivitz A, Tanaka Y, van der Heijde D, Simon JA, Baraf HSB, Kumar U, Matzkies F, Bartok B, Ye L, Guo Y, Tasset C, Sundy JS, Jahreis A, Genovese MC, Mozaffarian N, Landewé RBM, Bae SC, Keystone EC, Nash P. Combe B, et al. Among authors: keystone ec. Ann Rheum Dis. 2021 Jul;80(7):848-858. doi: 10.1136/annrheumdis-2020-219214. Epub 2021 Jan 27. Ann Rheum Dis. 2021. PMID: 33504485 Free PMC article. Clinical Trial.
Reply.
Fatima S, Schieir O, Keystone EC, Valois MF, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon C, Tin D, Thorne C, Bykerk VP, Pope JE; CATCH Investigators. Fatima S, et al. Among authors: keystone ec. Arthritis Rheumatol. 2022 Jan;74(1):178-180. doi: 10.1002/art.41918. Epub 2021 Dec 6. Arthritis Rheumatol. 2022. PMID: 34224658 No abstract available.
Treating rheumatoid arthritis to target: recommendations of an international task force.
Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T Expert Committee. Smolen JS, et al. Among authors: keystone ec. Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9. Ann Rheum Dis. 2010. PMID: 20215140 Free PMC article.
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
Keystone EC, Taylor PC, Tanaka Y, Gaich C, DeLozier AM, Dudek A, Zamora JV, Cobos JAC, Rooney T, Bono S, Arora V, Linetzky B, Weinblatt ME. Keystone EC, et al. Ann Rheum Dis. 2017 Nov;76(11):1853-1861. doi: 10.1136/annrheumdis-2017-211259. Epub 2017 Aug 10. Ann Rheum Dis. 2017. PMID: 28798049 Free PMC article. Clinical Trial.
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group. Cohen SB, et al. Among authors: keystone ec. Arthritis Rheum. 2006 Sep;54(9):2793-806. doi: 10.1002/art.22025. Arthritis Rheum. 2006. PMID: 16947627 Free article. Clinical Trial.
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK. Weinblatt ME, et al. Among authors: keystone ec. Arthritis Rheum. 2003 Jan;48(1):35-45. doi: 10.1002/art.10697. Arthritis Rheum. 2003. PMID: 12528101 Free article. Clinical Trial.
Rheumatoid arthritis: where are we now?
Smolen J, Keystone EC. Smolen J, et al. Among authors: keystone ec. Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v1-2. doi: 10.1093/rheumatology/kes112. Rheumatology (Oxford). 2012. PMID: 22718921 No abstract available.
Intravenous golimumab in rheumatoid arthritis.
Cohen MD, Keystone EC. Cohen MD, et al. Among authors: keystone ec. Expert Rev Clin Immunol. 2014 Jul;10(7):823-30. doi: 10.1586/1744666X.2014.918847. Epub 2014 May 15. Expert Rev Clin Immunol. 2014. PMID: 24831189 Review.
Infections that cause vasculitis.
Mader R, Keystone EC. Mader R, et al. Among authors: keystone ec. Curr Opin Rheumatol. 1992 Feb;4(1):35-8. Curr Opin Rheumatol. 1992. PMID: 1543661 Review.
289 results